Armata Pharmaceuticals (ARMP) Tax Provisions (2015 - 2017)

Armata Pharmaceuticals (ARMP) reported Tax Provisions of -$1.3 million for Q2 2017, down 1683.56% sequentially from -$73000.0 in Q4 2015.

Armata Pharmaceuticals (ARMP) Tax Provisions (2015 - 2017) Analysis & Trends

Armata Pharmaceuticals (ARMP) has 2 years of Tax Provisions data on file, last reported at -$1.3 million in Q2 2017.

For the quarter ending Q2 2017, Tax Provisions changed N/A year-over-year to -$1.3 million; the trailing twelve-month figure through Dec 2017 stood at -$1.4 million (changed N/A YoY), and the FY2018 full-year result was -$328000.0, up 74.81% from the prior year.
Tax Provisions eased to -$1.3 million in Q2 2017, from -$73000.0 in the prior quarter.
In the past five years, Tax Provisions ranged from a high of -$73000.0 in Q4 2015 to a low of -$1.3 million in Q2 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	125,146.46
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	31.86 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	188,883.60
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	221.50 Mn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	104.00 Mn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	179.00 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Armata Pharmaceuticals	191.29 Mn	186.49 Mn	-	-

Download Data

Date	Value
Jun 30, 2017	-1.30 Mn
Dec 31, 2015	-73,000.00